Relevant bibliographies by topics / Pregnancy Trimester, Third Australia

Academic literature on the topic 'Pregnancy Trimester, Third Australia'

Author: Grafiati
Published: 10 December 2022
Last updated: 29 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Pregnancy Trimester, Third Australia.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Pregnancy Trimester, Third Australia"

1

Mutia Nadra Maulida. "Effleurage Massage for Pain Relief in Pregnant Women." Conferences of Medical Sciences Dies Natalis Faculty of Medicine Universitas Sriwijaya 2, no. 1 (November 12, 2020): 185–97. http://dx.doi.org/10.32539/dies.v2i1.54.

Full text
Abstract:
Pregnancy is an event that begins with conception and ends with the onset of labor. Pregnancy is divided into three trimesters, the first trimester (0-12 weeks), the second trimester (13-27 weeks), and the third trimester (28-40 weeks). During the pregnancy process will cause various changes in all body systems, both physiological changes and psychological changes that can cause discomfort to pregnant women. Physiological changes that often occur in pregnant women such as dyspnea, insomnia, gingivitis, frequent urination, pressure and discomfort in the perineum, back pain, constipation, varicose veins, fatigue, Braxton hicks contractions, leg cramps, ankle edema. Not only physiologically, changes in pregnant women also occur psychologically such as changes in mood and increased anxiety.One of the physiological changes that pregnant women often complain about is back pain. According to Ratih (2016), the results of research on pregnant women in various regions of Indonesia reached 60-80% of people who experience back pain in their pregnancy. The reported prevalence of back pain in pregnancy varies from 50% in the UK and Scandinavia to 70% in Australia. Back pain experienced by pregnant women will peak at week 24 to week 28, just before abdominal growth reaches its maximum point. Most back pain during pregnancy occurs due to changes in the spinal muscles, as much as 70%.Back pain in pregnant women can be treated both pharmacologically and non pharmacologically. One of the non-pharmacological therapies that can be given is Effleurage Massage, which provides a gentle, slow and uninterrupted massage on the back of pregnant women so that it can cause relaxation and reduce pain.
APA, Harvard, Vancouver, ISO, and other styles
2

Robinson, Helen, Philip Robinson, Michael D’Emden, and Kassam Mahomed. "Management of thyroid disease in pregnancy – Room for improvement in the first trimester." Obstetric Medicine 9, no. 3 (June 21, 2016): 126–29. http://dx.doi.org/10.1177/1753495x16629773.

Full text
Abstract:
Background First-trimester care of maternal thyroid dysfunction has previously been shown to be poor. This study evaluates early management of thyroid dysfunction in pregnancy in Australia. Methods Patients reviewed by the Obstetric Medicine team for thyroid dysfunction from 1 January 2012 to 30 June 2013 were included. Data were collected on gestation at referral from the patient’s general practitioner to the antenatal clinic, information provided in the referral letter, thyroid function tests and thyroid medications. Results Eighty-five women were included in the study. At the time of general practitioner referral to antenatal services, 19% of women with preexisting thyroid disease had no thyroid function tested. Forty-three percent had an abnormal thyroid-stimulating hormone defined as being outside the laboratory-specific pregnancy reference range if available, or outside the level of 0.1–2.5 mIu/L in the first trimester, 0.2–3.0 mIu/L in the second trimester and 0.3–3.0 mIu/L in the third trimester. Only 21% of women increased their thyroxine dose prior to their first antenatal clinic review. Conclusion This study highlights that a significant proportion of women with known thyroid disease either have untested thyroid function in the first trimester or a thyroid-stimulating hormone outside of levels recommended by guidelines.
APA, Harvard, Vancouver, ISO, and other styles
3

Ghimire, Pramesh Raj, Gretchen Buck, Jackie Jackson, Emma Woolley, Rebekah Bowman, Louise Fox, Shirlena Gallagher, Malindey Sorrell, and Lorraine Dubois. "Impact of Antenatal Care on Perinatal Outcomes in New South Wales, Australia: A Decade-Long Regional Perspective." International Journal of Environmental Research and Public Health 20, no. 2 (January 5, 2023): 977. http://dx.doi.org/10.3390/ijerph20020977.

Full text
Abstract:
Low birth weight (LBW) and preterm birth are adverse perinatal outcomes that pose a significant risk to a child’s healthy beginning. While antenatal care (ANC) is an established intervention for pregnancy care, little is understood about how the number and timing of ANC visits can impact these adverse health outcomes. This study aimed to examine the impact of the number and timing of ANC visits on LBW and preterm birth in a regional setting. A decade-long perinatal dataset related to singleton live births that took place in the Southern New South Wales Local Health District (SNSWLHD) was utilized. The outcomes of interest were LBW and preterm birth, and the exposure variables were based on the Australian pregnancy guidelines on the number and timing of ANC visits. A multivariable logistic regression was performed to measure the association between outcome and exposure while adjusting for potential confounders. A greater level of protection against LBW and preterm birth was observed among mothers who had an adequate number of visits, with early entry (first trimester) into ANC. The protective effect of an adequate number of ANC visits against LBW and preterm birth among mothers with late entry into ANC (third trimester) was found to be statistically non-significant.
APA, Harvard, Vancouver, ISO, and other styles
4

Beetham, Kassia S., Jemima G. Spathis, Samantha Hoffmann, Wendy J. Brown, Vicki Clifton, and Gregore I. Mielke. "Longitudinal association of physical activity during pregnancy with maternal and infant outcomes: Findings from the Australian longitudinal study of women’s health." Women's Health 18 (January 2022): 174550572211423. http://dx.doi.org/10.1177/17455057221142357.

Full text
Abstract:
Background: Physical activity has known benefits during pregnancy; however, the optimum volume of physical activity through the different stages of pregnancy is not well known. Objectives: The aims of this study were to investigate the associations of physical activity volume in pregnant women in each trimester of pregnancy with maternal and infant outcomes. Design: The study involved 1657 pregnant women from the Australian Longitudinal Study on Women’s Health, who completed surveys from 2006 to 2012 (aged 28–39 years). Methods: Women reported being in either the first, second or third trimester of pregnancy. Women were grouped into four groups according to their self-reported physical activity during pregnancy: (1) Nil (0–<33.3 MET.min/week), (2) Low (33.3–<500 MET.min/week), (3) Moderate (500–<1000 MET.min/week) and (4) High (⩾1000 MET.min/week). Women who reported their physical activity during pregnancy completed a survey within three years after the birth, relating to outcomes associated with pregnancy and childbirth (gestational diabetes, hypertension, and antenatal depression and anxiety) and infant outcomes (birthweight and prematurity). Results: There was no association of physical activity in any trimester with infant birthweight, prematurity, gestational diabetes, hypertension or antenatal depression. Antenatal anxiety was less prevalent in women who reported low (1.7%) or moderate (1.1%) physical activity than in those who reported no activity (4.7%; p = 0.01). Conclusion: Different amounts of physical activity during pregnancy were not associated with the measured adverse health outcomes. However, low and moderate amounts of physical activity were associated with reduced incidence of antenatal anxiety.
APA, Harvard, Vancouver, ISO, and other styles
5

Fealy, Shanna, Jenna Hollis, Julia Martin, Lucy Leigh, Christopher Oldmeadow, Clare E. Collins, Roger Smith, Shelley Wilkinson, and Alexis Hure. "Modeling the Predictive Value of Evidence-Based Referral Criteria to Support Healthy Gestational Weight Gain among an Australian Pregnancy Cohort." Nutrients 14, no. 2 (January 17, 2022): 381. http://dx.doi.org/10.3390/nu14020381.

Full text
Abstract:
Globally, there has been a renewed focus on addressing gestational weight gain (GWG). In Australia, the Department of Health pregnancy care guidelines recommend women be offered routine weighing and receive brief nutritional and physical activity support during antenatal care visits. Women gaining weight outside the Institute of Medicine (IOM)’s weight gain reference values are further recommended to be referred to a dietitian. However, professional and organizational barriers, including an absence of weight gain referral pathways and limited workforce resources, exist with the translation and scaling of these recommendations into practice. This study aimed to explore patterns of GWG among a cohort of Australian pregnant women and to determine if pregnancy weight gains of above or below 2 kg or 5 kg in the second and third trimester can be used to predict total GWG outside recommendations. Sensitivity, specificity, negative, and positive likelihood ratios were calculated. The most predictive time point was 24 weeks’ gestation using the minimum weight change parameter of +/−2 kg, demonstrating reasonable sensitivity (0.81, 95% CI 0.61–0.83) and specificity (0.72, 95% CI 0.61–0.83), resulting in 55% (n = 72/131) of the cohort qualifying for dietetic referral. Given the current health service constraints, a review of dietetic services within maternity care is warranted.
APA, Harvard, Vancouver, ISO, and other styles
6

DODD, Jodie, Lauri O'BRIEN, and Judy COFFEY. "Misoprostol for second and third trimester termination of pregnancy: A review of practice at the Women's and Children's Hospital, Adelaide, Australia." Australian and New Zealand Journal of Obstetrics and Gynaecology 45, no. 1 (February 2005): 25–29. http://dx.doi.org/10.1111/j.1479-828x.2005.00338.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Buchanan, Limin, Emi Anderson, Huilan Xu MBiostat, Philayrath Phongsavan, Chris Rissel, and Li Ming Wen. "Sources of information and the use of mobile applications for health and parenting information during pregnancy: Implications for health promotion." Health Informatics Journal 27, no. 3 (July 2021): 146045822110431. http://dx.doi.org/10.1177/14604582211043146.

Full text
Abstract:
This study aims to examine the characteristics of pregnant women who used and intended to use mobile applications (apps) for health and parenting information. We used data from a randomised controlled trial, Communicating Healthy Beginnings Advice by Telephone (CHAT), conducted in Australia. Telephone surveys were conducted in 2017 to collect information on women’s demographic characteristics, sources of health and parenting information and willingness to use mobile apps. Multiple logistic regression was used to examine the associations of women’s socio-demographic backgrounds, their mobile apps usage and their willingness to use such apps. Data included 1155 pregnant women in their third trimester. Women from culturally and linguistically diverse backgrounds and with lower income appeared to have lower uptake of mobile apps despite high ownership of smart devices. Development of evidence-based and culturally-adapted mobile apps represent an important opportunity for healthcare providers to optimise maternal and birth outcomes.
APA, Harvard, Vancouver, ISO, and other styles
8

Pierce, Heather, Caroline S. E. Homer, Hannah G. Dahlen, and Jenny King. "Pregnancy-Related Lumbopelvic Pain: Listening to Australian Women." Nursing Research and Practice 2012 (2012): 1–10. http://dx.doi.org/10.1155/2012/387428.

Full text
Abstract:
Objective. To investigate the prevalence and nature of lumbo-pelvic pain (LPP), that is experienced by women in the lumbar and/or sacro-iliac area and/or symphysis pubis during pregnancy.Design. Cross-sectional, descriptive study.Setting. An Australian public hospital antenatal clinic. Sample population: Women in their third trimester of pregnancy.Method. Women were recruited to the study as they presented for their antenatal appointment. A survey collected demographic data and was used to self report LPP. A pain diagram differentiated low back, pelvic girdle or combined pain. Closed and open ended questions explored the experiences of the women.Main Outcome Measures. The Visual Analogue Scale and the Oswestry Disability Index (Version 2.1a).Results. There was a high prevalence of self reported LPP during the pregnancy (71%). An association was found between the reporting of LPP, multiparity, and a previous history of LPP. The mean intensity score for usual pain was 6/10 and four out of five women reported disability associated with the condition. Most women (71%) had reported their symptoms to their maternity carer however only a small proportion of these women received intervention.Conclusion. LPP is a potentially significant health issue during pregnancy.
APA, Harvard, Vancouver, ISO, and other styles
9

Pereira, Lenore, Takako Tabata, and Matthew Petitt. "Cytomegalovirus infection and pathogenesis in the human placenta." Microbiology Australia 36, no. 4 (2015): 171. http://dx.doi.org/10.1071/ma15061.

Full text
Abstract:
Human cytomegalovirus (HCMV) is the most common cause of congenital viral infection. Affected children can have permanent neurological complications, including hearing loss, visual impairment and mental retardation1–3. In Australia, 57% of women are seronegative and at risk for primary infection and transmission of virus to the fetus during pregnancy4. Despite its public health significance, the specific molecular and cellular basis of HCMV replication in the human placenta and pathogenesis associated with poor clinical outcome are unknown. Direct fetal infection is involved in severe cases of neuropathology and infection of the placenta can impair its development and functions resulting in a hypoxic environment5–8 and stillbirth6,9,10. Gestational age at the time of infection is an important determinant of outcome. The rates of virus transmission increase from 30% in first trimester to over 70% in third trimester suggesting different mechanisms for overcoming the placental barrier2. Remarkable insights into viral pathogenesis factors that function in the tissue environment have been gained by studying congenitally infected placentas and explants infected by clinical strains ex vivo. Together these studies revealed that direct infection of specialised placental cells and paracrine factors contribute to impaired development and functional defects.
APA, Harvard, Vancouver, ISO, and other styles
10

Di Ciaccio, Pietro R., Belinda Campbell, Kylie D. Mason, Mohamed Shanavas, Matthew Greenwood, Gareth P. Gregory, Renee Eslick, et al. "Lymphoma during Pregnancy: A Multicentre Study By the Australasian Lymphoma Alliance." Blood 138, Supplement 1 (November 5, 2021): 882. http://dx.doi.org/10.1182/blood-2021-150538.

Full text
Abstract:
Abstract Introduction Lymphoma complicates approximately 1/6000 pregnancies (Pereg, Haematologica 2007), and presents challenges for the patient, her family, and medical professionals. This rare event raises unique therapeutic, social and ethical issues, with the welfare of both mother and unborn child to consider. There are challenges regarding symptom obfuscation, diagnosis delays and treatment delivery. In this retrospective study, we aimed to describe the experience, treatment patterns and outcomes of lymphoma in pregnancy in Australia and New Zealand. Methods We identified patients aged ≥18 diagnosed with lymphoma in pregnancy between 1 January 2009 and 31 December 2020 , across 11 institutions in Australia and New Zealand. We defined "lymphoma in pregnancy" as diagnoses occurring during pregnancy (antenatal cases) or the first 12 months after delivery (postpartum cases). Postpartum cases were included to account for the phenomenon of diagnostic delay during gestation due to deferral of diagnostic investigations and symptom obfuscation (de Haan, Lancet Oncol 2018). Overall survival was calculated by Kaplan-Meier methods from the date of diagnosis to death, with patients alive and lost to follow-up censored on the last day of follow-up. Results We identified 63 patients, 34 diagnosed antepartum and 29 diagnosed postpartum (Table 1). The most common diagnoses were classical Hodgkin lymphoma (HL) (35), followed by diffuse large B cell lymphoma (11) and primary mediastinal B cell lymphoma (6). The median age was 32 (range 23-42) years. Women diagnosed antepartum were more likely to be nulliparous (p=0.004). Of the postpartum cases, symptoms of malignancy first appeared during pregnancy in 24%. At diagnosis, 44% had advanced stage disease. 60% of women had PET as part of baseline staging, however only 8% underwent PET whilst pregnant, all during the second or third trimester. 83% of HL patients had adverse risk factors (mediastinal bulk &gt;1/3 diameter, ESR&gt;50mm/hr, &gt;2 sites). ESR alone, which may be elevated physiologically in pregnancy, was the sole adverse risk factor for 9% of HL patients. Median days between diagnosis and treatment initiation were 14 (IQR 8-30) for antenatal patients and 21 (IQR 7-40) for postnatal. 19% of the antenatal cohort with aggressive lymphoma had treatment deferred/delayed explicitly due to pregnancy. The majority (89%) of antenatal patients were treated with ABVD (HL) or (R)CHOP/(R)EPOCH (NHL) whilst pregnant. 3 patients received first-line treatment divergent from standard (vinblastine for HL, interferon for indolent B-NHL and surgery for primary cutaneous ALCL). 37% received radiotherapy, although only 1 patient received it antenatally. Median follow up was 34 months. 5 year OS for HL was 83% (95%CI 54%-95%) and for DLBCL 74% (95%CI 30%-93%)(Figure 1). Seven patients died (4 from lymphoma, 2 treatment-related infection, 1 unknown). Discussion of elective termination of pregnancy was documented in 24 of 34 antenatal diagnoses, advised in 3 and performed in 2, both in the first trimester. Only 31 (49%) of 63 women had documented evidence of counselling regarding future fertility strategies. Of the 48 patients with available data, there were 45 live births, 2 elective terminations and 1 spontaneous abortion in the first trimester. The mean gestation at birth was significantly earlier and marginally preterm for antenatal diagnoses (mean 35.6wk v 38.2wk, p=0.002). 6 neonates (11%) were small for gestational age, 5 of whom were born to mothers diagnosed antenatally. 29% of neonates were admitted to neonatal intensive care or special care units. There were no cases of neonatal neutropenia, one case of sepsis of prematurity and one case of PJP infection in a term baby. Conclusion Lymphoma in pregnancy is rare and lacks a harmonised approach. We present a large multicentre cohort reflecting contemporary practice. Although standard therapy could be provided to most patients, delays in treatment and diagnosis were common, and most antenatally-diagnosed women did not receive optimal staging. Neonates in the antenatally-diagnosed group were more likely to be premature, however there are likely a number of confounders and causality cannot be presumed. There were no neonatal deaths. It is imperative to continue to report on data regarding lymphoma in pregnancy to inform optimal care in this setting. Figure 1 Figure 1. Disclosures Greenwood: Amgen: Membership on an entity's Board of Directors or advisory committees, Research Funding; Pfizer: Membership on an entity's Board of Directors or advisory committees; Servier: Membership on an entity's Board of Directors or advisory committees, Research Funding; Jazz Pharmaceuticals: Membership on an entity's Board of Directors or advisory committees. Gregory: Janssen: Consultancy; Novartis: Consultancy; Roche: Honoraria, Membership on an entity's Board of Directors or advisory committees, Other: Travel fees, Speakers Bureau. Hamad: Novartis: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Pregnancy Trimester, Third Australia"

1

Goode, Natasha Diane, and Natasha Diane Goode. "Assessment of Tdap Administration in the Third Trimester of Pregnancy." Diss., The University of Arizona, 2017. http://hdl.handle.net/10150/625597.

Full text
Abstract:
Introduction: In 2012, the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention expanded their recommendation for the Tdap vaccination to include the antepartum period. Regardless of immunization history, the recommendation states that medical practitioners should administer the Tdap vaccination to every pregnant woman in each occurring pregnancy (Munoz, et al., 2014; Shakib, et al., 2013; Goldfarb, Little, Brown, Riley, 2014). Methods: To describe treatment practices and uptake of Tdap vaccine, a cross-sectional descriptive survey design was utilized. The purpose of survey is to gather information regarding prevalence, distribution, and interrelations of variables within a population (Polit & Beck). In this study, the survey questionnaire was conducted in an online format. Results: Of the six HBM questions included in the study, except for question four, the results of the chi-squared analysis suggest that any single measured dimension of the HBM cannot predict a health behavior, in this case receipt of the Tdap vaccination. The population is split regarding infants' perceived susceptibility to pertussis infection. Strong agreement to the benefit of vaccination was revealed. Question six regarded available information, although the majority were satisfied a significant percentage indicated a desire for more information. Discussion: This Doctorate of Nursing Practice project developed a survey based on the Health Belief Model with the intention of assessing perceived susceptibility, perceived severity, perceived benefits and perceived barriers to the health care preventative action of receiving the Tdap vaccination in the third trimester of pregnancy. Through in-depth literature review, consideration of the updated ACIP guidelines, and support of a developed theoretical framework, an eight-question survey was developed. The data examined in this project may serve to illustrate limitations in provider care that can be immediately improved upon, such as information sharing. The primary limitation of the study is in the sample size of 44 eligible survey responses and the uniform demographics of the population. Despite these limitations, the survey design may be extended to other populations of interest, with greater demographic variation for further study.
APA, Harvard, Vancouver, ISO, and other styles
2

Chen, Yang, Liang Wang, Maosun Fu, Jie Wang, Arsham Alamian, and Marc Jr Stevens. "Risk Factors of Mental Health Disorder among Chinese Women in Third Trimester of Pregnancy." Digital Commons @ East Tennessee State University, 2013. https://dc.etsu.edu/etsu-works/1401.

Full text
Abstract:
Mental health disorder is the leading cause of disease burden in women worldwide. Pregnant women with mental disorder are especially at risk of having offspring with adverse outcomes. This study aimed to investigate risk factors of mental health disorder among Chinese pregnant women in the third trimester. A total of 462 pregnant women in their third trimester completed interviews at three hospitals in Shandong Province, China from July to December, 2010. The Symptom Checklist-90-R (SCL-90-R) was used to evaluate mental health disorder, and was defined as total score ≥160, or scores of any symptom dimensions ≥3, or total of positive symptoms ≥43. Multiple logistic regression was used to examine the risk factors of mental health disorder, and to adjust for covariates. The total score and scores of somatization, obsessive-compulsive, anxiety, and phobic anxiety were higher than corresponding national norm by SCL-90-R assessment (all p<0.05). Multiple logistic regression showed family income, relationship with parents-in-law, concerns about child's health, fear of delivery, and pregnancy complications were negatively associated with mental health disorder (all p<0.05). More specifically, relationship with parents-in-law, fear of delivery, preference on mode of delivery (Caesarean section), and body image concerns were positively associated with anxiety (all p<0.05); Fear of delivery was positively associated with depression (p=0.023). Family income, relationship with parents-in-law, concern about child's health, fear of delivery, and pregnancy complications were identified as potential risk factors of mental health disorder in this Chinese pregnant women population. Strategies to reduce mental health disorder are needed among Chinese pregnant women.
APA, Harvard, Vancouver, ISO, and other styles
3

Bailey, Beth, Judy G. McCook, Andrea Clements, and Lana McGrady. "Quitting Smoking During Pregnancy and Birth Outcomes: Evidence of Gains Following Cessation by Third Trimester." Digital Commons @ East Tennessee State University, 2011. https://dc.etsu.edu/etsu-works/7189.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bailey, Beth A., Judy G. McCook, A. L. Hodge, Andrea D. Clements, and Lana McGrady. "Quitting Smoking During Pregnancy and Birth Outcomes: Evidence of Gains Following Cessation by Third Trimester." Digital Commons @ East Tennessee State University, 2011. https://dc.etsu.edu/etsu-works/7278.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Nodine, Janet Lynn. "THE EFFECT OF THERAPEUTIC TOUCH ON ANXIETY AND WELL-BEING IN THIRD TRIMESTER PREGNANT WOMEN." Thesis, The University of Arizona, 1987. http://hdl.handle.net/10150/276506.

Full text
Abstract:
This study was conducted to determine whether or not a significant difference exists in pregnant women among those receiving therapeutic touch, mock therapeutic touch, or no touch on measurements of anxiety and well-being. Thirty third trimester primigravida subjects were tested pre- and postintervention using the State-Anxiety Inventory and a Well-Being Visual Analog; heart and respiratory rates were monitored before, during, and after the treatment. No significant differences were found using analysis of covariance with the pre-test scores as the covariate. The findings indicate that therapeutic touch may not be useful in reducing state anxiety or enhancing subjective well-being in pregnancy. Study limitations include a small sample size, use of an instrument without established reliability and validity, and a study environment that may have increased anxiety.
APA, Harvard, Vancouver, ISO, and other styles
6

Lynn, F. A. "The value of a third trimester ultrasound scan in low-risk pregnancy; a discrete choice approach." Thesis, Queen's University Belfast, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.517102.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Khan, Fauzia Asadullah. "An evaluation of magnesium status and inflammatory response during the third trimester of normal pregnancy and preeclampsia." Diss., Mississippi State : Mississippi State University, 2008. http://library.msstate.edu/etd/show.asp?etd=etd-08092008-101853.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Gelaye, Bizu, Amber Domingue, Fernanda Rebelo, Lauren E. Friedman, Chunfang Qiu, Sixto E. Sanchez, Gloria Larrabure-Torrealva, and Michelle A. Williams. "Association of antepartum suicidal ideation during the third trimester with infant birth weight and gestational age at delivery." Routledge, 2019. http://hdl.handle.net/10757/625044.

Full text
Abstract:
El texto completo de este trabajo no está disponible en el Repositorio Académico UPC por restricciones de la casa editorial donde ha sido publicado.
Antepartum suicidal behaviors are a leading cause of maternal injury and death. Previous research has not investigated associations between antepartum suicidal ideation and perinatal complications. Our study objective was to evaluate the relationship of antepartum suicidal ideation with low infant birthweight, small for gestational age, and preterm birth. A cohort study was conducted among 1,108 women receiving prenatal care in Peru. Suicidal ideation was measured using the Patient Health Questionnaire-9 during pregnancy. Birth outcomes were extracted from medical records. Linear regressions and multivariable logistic regressions were used to estimate were used to investigate associations between suicidal ideation and pregnancy outcomes. The prevalence of suicidal ideation was 8.7%, preterm delivery was 5.7%, low birthweight was 4.4%, and small for gestational age was 3.4%. In an adjusted model, infant birthweight was 94.2 grams lower for mothers with antepartum suicidal ideation (95% CI: −183.0, −5.5, p = 0.037) compared with those without suicidal ideation. After adjusting for confounders including depression, participants with suicidal ideation had a nearly four-fold increased odds of delivering a small for gestational age infant (OR: 3.73; 95% CI: 1.59–8.74). These findings suggest suicidal ideation during pregnancy is associated with adverse perinatal outcomes, especially low infant birthweight.
Revisión por pares
APA, Harvard, Vancouver, ISO, and other styles
9

Gelaye, Bizu, Amber Domingue, Fernanda Rebelo, Lauren E. Friedman, Chunfang Qiu, Sixto E. Sanchez, Gloria Larrabure-Torrealva, and Michelle A. Williams. "Association of antepartum suicidal ideation during the third trimester with infant birth weight and gestational age at delivery." Routledge, 2018. http://hdl.handle.net/10757/624715.

Full text
Abstract:
El texto completo de este trabajo no está disponible en el Repositorio Académico UPC por restricciones de la casa editorial donde ha sido publicado.
Antepartum suicidal behaviors are a leading cause of maternal injury and death. Previous research has not investigated associations between antepartum suicidal ideation and perinatal complications. Our study objective was to evaluate the relationship of antepartum suicidal ideation with low infant birthweight, small for gestational age, and preterm birth. A cohort study was conducted among 1,108 women receiving prenatal care in Peru. Suicidal ideation was measured using the Patient Health Questionnaire-9 during pregnancy. Birth outcomes were extracted from medical records. Linear regressions and multivariable logistic regressions were used to estimate were used to investigate associations between suicidal ideation and pregnancy outcomes. The prevalence of suicidal ideation was 8.7%, preterm delivery was 5.7%, low birthweight was 4.4%, and small for gestational age was 3.4%. In an adjusted model, infant birthweight was 94.2 grams lower for mothers with antepartum suicidal ideation (95% CI: −183.0, −5.5, p = 0.037) compared with those without suicidal ideation. After adjusting for confounders including depression, participants with suicidal ideation had a nearly four-fold increased odds of delivering a small for gestational age infant (OR: 3.73; 95% CI: 1.59–8.74). These findings suggest suicidal ideation during pregnancy is associated with adverse perinatal outcomes, especially low infant birthweight.
Revisión por pares
APA, Harvard, Vancouver, ISO, and other styles
10

Brinkley, Renee Lynn. "The Correlation Between Perceived Stress and Health Promoting Self-care Behaviors in High-risk Third Trimester Pregnancies." University of Toledo Health Science Campus / OhioLINK, 2004. http://rave.ohiolink.edu/etdc/view?acc_num=mco1085680561.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Pregnancy Trimester, Third Australia"

1

Kao, Chien-Huei. First time Taiwanese fathers' lived experiences during the third trimester of their wives' pregnancy, labour and delivery and the initial postnatal period: a phenomenological study. [S.l: The author], 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Sharma, Alok. Practical Guide to Third Trimester of Pregnancy and Puerperium. Jaypee Brothers Medical Publishers, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Renzo, Gian Carlo Di, Andrea Tinelli, and Antonio Malvasi. Management and Therapy of Late Pregnancy Complications: Third Trimester and Puerperium. Springer, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Renzo, Gian Carlo Di, Andrea Tinelli, and Antonio Malvasi. Management and Therapy of Late Pregnancy Complications: Third Trimester and Puerperium. Springer, 2017.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

A Practical Guide to Third Trimester of Pregnancy and Puerperium. Jaypee Brothers Medical Publishers (P) Ltd., 2016. http://dx.doi.org/10.5005/jp/books/12870.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Pubilishing, Bikan's. Hello third trimester goodbye feet: Pregnancy gifts for mom pregnancy day by day book. Independently published, 2019.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Liebman, Sammi Siegel. THE EFFECTS OF MUSIC AND RELAXATION ON THIRD TRIMESTER ANXIETY IN ADOLESCENT PREGNANCY (PREGNANCY). 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

1947-, Roe Jane, and Birth Control Trust, eds. Reducing late abortions: Access to NHS services in early pregnancy : proceedings of a conference organised by the Birth Control Trust on 16 September 1987 at the Royal Society of Medicine, London. [London]: The Trust, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Brady-Freitag, Nancy Lee. PHYSIOLOGICAL AND PSYCHOLOGICAL CORRESPONDENCE BETWEEN PARENTAL PAIRS IN THE THIRD TRIMESTER (PREGNANCY, COUVADE SYNDROME). 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Jacques, Sharon Lee. THE EFFECT OF A NURSING INTERVENTION DURING THE THIRD TRIMESTER ON MATERNAL-FETAL ATTACHMENT AND PREGNANCY OUTCOMES. 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Pregnancy Trimester, Third Australia"

1

Potts, Stacy, and Sara G. Shields. "Third Trimester." In Women-Centered Care in Pregnancy and Childbirth, 83–90. London: Routledge, 2022. http://dx.doi.org/10.4324/9780429272219-19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Skomorovsky, Elena, John Gullett, and David C. Pigott. "Second- and Third-Trimester Pregnancy." In Emergency Point-of-Care Ultrasound, 143–51. Chichester, UK: John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781119072874.ch12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Jivraj, Shehnaaz. "Obstetric Complications in Patients with Recurrent Miscarriage - How Should they be Monitored in the Third Trimester?" In Recurrent Pregnancy Loss, 115–27. Oxford: John Wiley & Sons, Ltd, 2013. http://dx.doi.org/10.1002/9781118749012.ch11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Philip, John. "Prenatal Diagnosis and Management of Congenital Malformations in the Third Trimester of Pregnancy." In Genetic Disorders and the Fetus, 775–98. Boston, MA: Springer US, 1986. http://dx.doi.org/10.1007/978-1-4684-5155-9_27.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Axt-Fliedner, Roland, and Aline Wolter. "Prenatal Diagnosis and Management of Abnormal Fetal Development in the Third Trimester of Pregnancy." In Genetic Disorders and the Fetus, 599–659. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2015. http://dx.doi.org/10.1002/9781118981559.ch14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Wladimiroff, Juriy W., and Titia E. Cohen-Overbeek. "Prenatal Diagnosis and Management of Abnormal Fetal Development with Emphasis on the Third Trimester of Pregnancy." In Genetic Disorders and the Fetus, 882–910. Oxford, UK: Wiley-Blackwell, 2010. http://dx.doi.org/10.1002/9781444314342.ch26.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Romm, Aviva, Laurel Lee, and Christopher Hobbs. "Pregnancy: Third Trimester." In Botanical Medicine for Women's Health, 370–97. Elsevier, 2010. http://dx.doi.org/10.1016/b978-0-443-07277-2.00017-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Pandey, Uma, and Stephen Lindow. "Third Trimester Bleeding." In A Practical Guide to Third Trimester of Pregnancy and Puerperium, 438. Jaypee Brothers Medical Publishers (P) Ltd., 2016. http://dx.doi.org/10.5005/jp/books/12870_46.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Gupta, Neha. "Imaging in Third Trimester." In A Practical Guide to Third Trimester of Pregnancy and Puerperium, 62. Jaypee Brothers Medical Publishers (P) Ltd., 2016. http://dx.doi.org/10.5005/jp/books/12870_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

West, Zita, and Lyndsey Isaacs. "Third trimester: 28 to 40 weeks." In Acupuncture in Pregnancy and Childbirth, 103–20. Elsevier, 2008. http://dx.doi.org/10.1016/b978-044310371-1.50010-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Pregnancy Trimester, Third Australia"

1

Wahyuningsih, Astri, Piscolia Dynamurti Wintoro, Wiwin Rohmawati, and Yuriyahtun Khasanah. "Anemia Incidence in a Third Trimester Pregnant of Adolescent Pregnancy." In 1st Borobudur International Symposium on Humanities, Economics and Social Sciences (BIS-HESS 2019). Paris, France: Atlantis Press, 2020. http://dx.doi.org/10.2991/assehr.k.200529.121.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hall, B., D. Kennedy-Little, and M. Khandelwal. "Tamponade, Tumor, and Third Trimester of Pregnancy: Unusual Physiology and Management." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3229.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kokovidou, T., T. Sivvas, and P. Tsikouras. "Antepartum bleeding second and third trimester of pregnancy and fetal outcome." In 62. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe – DGGG'18. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1671588.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Micalizzi, Lauren, and Rachel Gunn. "Cannabis Use in Pregnancy." In 2021 Virtual Scientific Meeting of the Research Society on Marijuana. Research Society on Marijuana, 2022. http://dx.doi.org/10.26828/cannabis.2022.01.000.39.

Full text
Abstract:
Concern for adverse effects of prenatal cannabis use (PCU) is warranted. The American Academy of Pediatrics recommends refraining from PCU, because Δ⁹-tetrahydrocannabinol (THC) crosses the placenta at approximately 10% of maternal levels, which can result in adverse offspring outcomes. Little is known about patterns and contexts of PCU; to advance this effort, 64 pregnant women who use cannabis were recruited from Amazon’s Mechanical Turk for a study of PCU thoughts and behaviors. Women were, on average, 22 years of age (range 22-49); mean income was ~$44,000 (range $0-$150,000). 53.3% of respondents were in the first trimester, 43.3% were in the second and 3.4% were in the third. Polysubstance use was common; 25% reported prenatal alcohol use and 64% reported prenatal tobacco use. Approximately 40% reported using about the same amount of cannabis as before pregnancy. Regarding availability and patterns, approximately 44% indicated that cannabis was “somewhat” or “very” easy to get. Women in the third trimester reported the most frequent PCU. Across all trimesters, the majority of women reported using cannabis with roughly equal parts THC and cannabidiol and PCU primarily consisted of consumption of leaf and concentrates. The most common modes of administration were joints in the first trimester and hand pipes in the second and third trimesters. On a typical PCU day, approximately 70% of participants reported consuming ¼ gram of flower or less, 73% reported taking 5 or fewer hits of concentrates, and 85% reported ingesting 10 milligrams of THC or less in edibles. PCU among social networks was prevalent; over 50% reported that their spouse/partner used cannabis during their pregnancy and approximately 80% reported that a few, several, or most of their family and friends use cannabis. Regarding contexts, during a typical week, women reported PCU in their homes (alone [30%], with others [54.7%]), at friends’ or family members’ homes (alone [28%], with others [39%]), in bars/nightclubs/restaurants/breweries (alone [30%], with others [34%]), as well as outdoors (alone [34%], with others [33%]), at work (alone [34%], with others [36%]), at school (alone [23%], with others [36%]), in the car (alone [31%], with others [36%]) or elsewhere (alone [23%], with others [39%]). PCU was perceived as ‘highly effective’ (as reported by 75-95%) at managing nausea, distress (anxiety, depression), and physical discomfort (e.g., backaches). Perceived harm of PCU was low, more than half of participants believed PCU would harm the fetus (~60%) or herself (~64%) “not at all” or “a little.” In conclusion, polysubstance use, particularly tobacco use, is common among women who use cannabis during pregnancy. Although quantity of PCU consumption was relatively low in our sample, any amount is concerning and may have negative impact on the developing fetus. The majority of women’s social networks used cannabis and, in all contexts (with the exception of outdoor use), PCU was typically in the company of others. Perceived efficacy of PCU for symptom modulation was high across a variety of conditions, and risk perceptions were low, both of which may result in riskier use trajectories.
APA, Harvard, Vancouver, ISO, and other styles
5

Puspita Sari, Endah, and Katrim Alifa Putrikita. "The Relationship Between Cognitive Emotion Regulation and Anxiety Among Women in the Third Trimester of Pregnancy." In 6th Annual International Conference on Cognitive and Behavioral Psychology (CBP 2017). Global Science & Technology Forum (GSTF), 2017. http://dx.doi.org/10.5176/2251-1865_cbp17.5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Singhartinger, J., A. Bertges, G. Kutschka, C. Böger, and C. Schindlbeck. "Rare case of acute renal failure due to Hemolytic-uremic Syndrome (HUS) in third trimester pregnancy." In Kongressabstracts zur Tagung 2020 der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG). © 2020. Thieme. All rights reserved., 2020. http://dx.doi.org/10.1055/s-0040-1717975.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

González Mota, Alba, Marina Covacho González, Isabel Valriberas Herrero, and Carlos Roncero Alonso. "Screening of cannabis use during pregnancy and neonates." In 22° Congreso de la Sociedad Española de Patología Dual (SEPD) 2020. SEPD, 2020. http://dx.doi.org/10.17579/sepd2020p090.

Full text
Abstract:
Introduction: Cannabis use in pregnancy is related to developmental and mental disorders. The acknowledgement of prenatal exposure frequently depends on the mother’s report, which can often be omitted. There exists little description in the literature of the different methods to detect the use of cannabis during pregnancy. Moreover, nowadays there is no standardized screening available. Objectives: The objective is to analyze the different methods of prenatal screening of cannabis during pregnancy. Methods: A systematic review of studies on the methods of screening of cannabis use during pregnancy and neonates was carried out in PubMed in July 2020 in English, French and Spanish including the last 10 years with the keywords: screening, test, detection, analysis, urine, blood, hair, meconium, lactation, milk, cannabis, marijuana, THC, pregnancy, pregnant, perinatal and prenatal. Results: 107 studies were analyzed, 52 studies included and 55 excluded. Urine toxicology is the most accurate method for maternal testing and depends on chronicity of use, since its duration varies from 2-3 days in occasional users to several weeks in chronic users. Neonatal meconium and umbilical cord tissue indicates fetal exposure to cannabinoids during second and third trimester, being cord tissue more rapidly available than meconium. Neonatal hair indicates third trimester exposure and it is less sensitive than meconium. Maternal serum and hair can also be used to assess cannabis use, being serum affected by chronicity with shorter half-life than urine, and hair less accurate than other drugs of abuse, lasting several weeks positive. To analyze the samples it typically involves a cleanup pretreatment, gas chromatography mass spectrometry (GC/MS), enzyme-linked inmunoabsorbent assay (ELISA) and/or an immunoassay screening and a liquid chromatography–tandem mass spectrometry (LC-MS/MS) confirmatory method. Conclusions: Standardized prenatal screening of cannabis during pregnancy using analytical methods for drug detection should be established to overcome the heterogeneity and improve clinical practice.
APA, Harvard, Vancouver, ISO, and other styles
8

Diana, Sulis, Chatarina Umbul Wahyuni, and Budi Prasetyo. "Effect of Obstructive Sleep Apnea on Incidence of Pre-eclampsy in Pregnant Women: A Systematic Review." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.03.82.

Full text
Abstract:
ABSTRACT Background: The prevalence of preeclampsia is around 5-8% of all diseases that occur during pregnancy. There was an increase from 10.5% of women with OSA in the first trimester to 26.7% in the third trimester. This study aimed to investigate the effect of obstructive sleep apnea on incidence of preeclampsia in pregnant women. Subjects and Method: A systematic review was conducted by searching the articles from PubMed and Google Scholar databases published between 2015 to 2019. An obstructive sleep apnoea (OSA) analysis was performed. Sensitivity analysis was performed to identify designs, summary results and publication estimates. Results: As many as 15 studies with a total of 1,837 subjects were included. OSA during pregnancy was associated with an increased risk of preeclampsia. The selected studies were conducted in observational designs. The existing studies showed that maternal OSA was significantly associated with preeclampsia (aOR= 1.96; 95% CI= 1.30 to 2.42). Conclusion: There is the adverse relationship of OSA and preeclampsia. OSA increases the risk of multiple pregnancy and perinatal complications. Keywords: preeclampsia, OSA, pregnancy Correspondence: Sulis Diana. Doctoral Program, Faculty of Public Health, Universitas Airlangga, Surabaya, East Java. Email: Diana.sulis6@gmail.com. Mobile: +6282234209942. DOI: https://doi.org/10.26911/the7thicph.03.82
APA, Harvard, Vancouver, ISO, and other styles
9

Nechaeva, Y. V., and N. А. Kozelko. "FEATURES OF COMPLICATIONS OF THE PERIOD OF PREGNANCY AND POSTNATAL CONDITIONS." In SAKHAROV READINGS 2021: ENVIRONMENTAL PROBLEMS OF THE XXI CENTURY. International Sakharov Environmental Institute, 2021. http://dx.doi.org/10.46646/sakh-2021-1-304-307.

Full text
Abstract:
The results of the study showed that among women attending the antenatal clinic “Borisov Central District Hospital”, urinary tract infections (26.9-32.3%) are the most frequently recorded . Anemia (16.3-18.2%) and venous complications (8.5-14.1%) are often recorded. Least of all of the considered complications in the third trimester is diabetes mellitus (5.2-5.4%). Bleeding in the follow-up and postpartum period for 2016-20 was 11.7% of cases. As a result of the analysis of the dynamics of the health status of women registered with the dispensary in the residential complex “Borisovskaya CRH” for the period from 2016-20, it was found that the dynamics of complications during pregnancy and the postpartum period is characterized by a pronounced steady downward trend (R2> 0.7).
APA, Harvard, Vancouver, ISO, and other styles
10

Forestier, F., F. Daffos, M. Rainaut, P. Cornu, A. Deschamps, and F. Toulemonde. "MAY LMW (CY 216) BE ADMINISTERED DURING PREGNANCY ?" In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643598.

Full text
Abstract:
One of the main problems related to the use of fractionated heparin during pregnancy concerns its transplacental passage.Previous studies showed LMW heparin fraction CY 216 has no teratogenic effects, and when labelled, does not cross the placental barrier in animal, and does not appear into the milk.We studied the transplacental passage following subcutaneous administration of large dosage (17.500 AXa IC u) in 7 women who where going to have an abortion during the third trimester of gestation because of severe fetal malformation, after informed consent.Blood samples were taken before and 3 h after injection from che mother , from the fetuses 3 h after mother injection -using ultrasound guidance of the needle and aspiration of blood in the umbilical vein.Biological assays showed that the effects are clearly observable in mother, whereas no change was observed from the fetus.Thus, it was justifiable to treat, for several reasons, 22 patients using CY 216 during a period of 2 to 5 weeks before delivery. Treatments were successful and no complication has been observed. The cord blood samples at birth never showed any biological activity.These data seem to clearly indicate that there is no passage through the placental barrier of CY 216 which offers a new possibility of treatment during pregnancy.
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Pregnancy Trimester, Third Australia"

1

Fields, Michael J., Mordechai Shemesh, and Anna-Riitta Fuchs. Significance of Oxytocin and Oxytocin Receptors in Bovine Pregnancy. United States Department of Agriculture, August 1994. http://dx.doi.org/10.32747/1994.7568790.bard.

Full text
Abstract:
Oxytocin has multiple actions in bovine reproductive tract and it was our purpose to determine the nature of these actions and their significance for the physiology of bovine reproduction. The bovine oxytocin receptors (OTR) gene was cloned and its expression studied during the cycle and pregnancy. OTR mRNA changed in parallel with OTR with control occurring mainly at the transcriptional level. However, the endocrine regulation of OTR were found in endometrium and cervical mucosa at estrus and at parturition. In both tissues OTR were suppressed in the luteal phase and early pregnancy. Whereas cervical OTR remained suppressed throughout pregnancy, endometrial OTR began to increase soon after implantation and reached higher concentrations in midpregnancy than at estrus. OTR in caruncles did not increase until third trimester, and OTR in cervical mucosa, cotyledons and fetal membranes increased only at term. Myometrial OTR showed less variation and OTR were present throughout the cycle and pregnancy but increased significantly during mid- and late pregnancy. OTR were localized in endometrial epithelial cells and lumina epithelial cells of cervical mucosa as determined by immunohistochemistry. Endometrial OTR were functional throughout pregnancy and mediated PGF release from day 50 onwards in a receptor density related manner. OTR in cervical mucosa mediated PGE release both in vivo and in vitro, as shown in cyclic cows. The ontogeny of uterine OTR was studied from third trimester fetal stage until puberty. OTR were present in endometrium and cervical mucosa in high concentrations throughout this period; myometrial OTR began to increase somewhat later but also reached adult values by 6-mo of age. In the prepuberal heifers OT injections failed to initiate PGF2a, release. The influence of steroids on the effect of OT was examined. Ovariectomy and E2 were without effect, but P4 with or without E2 induced a massive PGF2a release in response to OT in spite of reduced OTR. Bovine cyclooxygenases (COX-1 and COX-2) were cloned and their expression studied in the endometrium of prepuberal heifers and pregnant cows. Untreated and E2 treated prepuberal heifers did not express COX-2 but P4 treated heifers did express the mRNA for COX-2, albeit weakly. During the second half of pregnancy COX-2 mRNA was strongly expressed in cotyledons and somewhat less in caruncles, whereas endometrium, myometrium and cervical mucosa showed only weak, if any, COX-2 mRNA under basal conditions. However, 2 h after OT injection significant increases in COX-2 mRNA were found in endometrial RNA. Thus OT is capable of inducing the expression of the inducible COX-2 gene, and hence the conversion of arachidonic acid to prostanoids. The results indicate that the functions of OT are numerous and probably essential for successful pregnancy and parturition.
APA, Harvard, Vancouver, ISO, and other styles
2

Viswanathan, Meera, Jennifer Cook Middleton, Alison Stuebe, Nancy Berkman, Alison N. Goulding, Skyler McLaurin-Jiang, Andrea B. Dotson, et al. Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Systematic Review of Perinatal Pharmacologic Interventions. Agency for Healthcare Research and Quality (AHRQ), April 2021. http://dx.doi.org/10.23970/ahrqepccer236.

Full text
Abstract:
Background. Untreated maternal mental health disorders can have devastating sequelae for the mother and child. For women who are currently or planning to become pregnant or are breastfeeding, a critical question is whether the benefits of treating psychiatric illness with pharmacologic interventions outweigh the harms for mother and child. Methods. We conducted a systematic review to assess the benefits and harms of pharmacologic interventions compared with placebo, no treatment, or other pharmacologic interventions for pregnant and postpartum women with mental health disorders. We searched four databases and other sources for evidence available from inception through June 5, 2020 and surveilled the literature through March 2, 2021; dually screened the results; and analyzed eligible studies. We included studies of pregnant, postpartum, or reproductive-age women with a new or preexisting diagnosis of a mental health disorder treated with pharmacotherapy; we excluded psychotherapy. Eligible comparators included women with the disorder but no pharmacotherapy or women who discontinued the pharmacotherapy before pregnancy. Results. A total of 164 studies (168 articles) met eligibility criteria. Brexanolone for depression onset in the third trimester or in the postpartum period probably improves depressive symptoms at 30 days (least square mean difference in the Hamilton Rating Scale for Depression, -2.6; p=0.02; N=209) when compared with placebo. Sertraline for postpartum depression may improve response (calculated relative risk [RR], 2.24; 95% confidence interval [CI], 0.95 to 5.24; N=36), remission (calculated RR, 2.51; 95% CI, 0.94 to 6.70; N=36), and depressive symptoms (p-values ranging from 0.01 to 0.05) when compared with placebo. Discontinuing use of mood stabilizers during pregnancy may increase recurrence (adjusted hazard ratio [AHR], 2.2; 95% CI, 1.2 to 4.2; N=89) and reduce time to recurrence of mood disorders (2 vs. 28 weeks, AHR, 12.1; 95% CI, 1.6 to 91; N=26) for bipolar disorder when compared with continued use. Brexanolone for depression onset in the third trimester or in the postpartum period may increase the risk of sedation or somnolence, leading to dose interruption or reduction when compared with placebo (5% vs. 0%). More than 95 percent of studies reporting on harms were observational in design and unable to fully account for confounding. These studies suggested some associations between benzodiazepine exposure before conception and ectopic pregnancy; between specific antidepressants during pregnancy and adverse maternal outcomes such as postpartum hemorrhage, preeclampsia, and spontaneous abortion, and child outcomes such as respiratory issues, low Apgar scores, persistent pulmonary hypertension of the newborn, depression in children, and autism spectrum disorder; between quetiapine or olanzapine and gestational diabetes; and between benzodiazepine and neonatal intensive care admissions. Causality cannot be inferred from these studies. We found insufficient evidence on benefits and harms from comparative effectiveness studies, with one exception: one study suggested a higher risk of overall congenital anomalies (adjusted RR [ARR], 1.85; 95% CI, 1.23 to 2.78; N=2,608) and cardiac anomalies (ARR, 2.25; 95% CI, 1.17 to 4.34; N=2,608) for lithium compared with lamotrigine during first- trimester exposure. Conclusions. Few studies have been conducted in pregnant and postpartum women on the benefits of pharmacotherapy; many studies report on harms but are of low quality. The limited evidence available is consistent with some benefit, and some studies suggested increased adverse events. However, because these studies could not rule out underlying disease severity as the cause of the association, the causal link between the exposure and adverse events is unclear. Patients and clinicians need to make an informed, collaborative decision on treatment choices.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Pregnancy Trimester, Third Australia' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography